国际血栓与止血学会科学标准化委员会关于弥散性血管内凝血血管内皮相关生物标志物的通讯
该通讯指出弥散性血管内凝血(DIC)是伴随多种基础疾病的病理机制过程,内皮损伤是其必要组分,但现行诊断标准未纳入血管内皮损伤生物标志物。抗凝血酶活性和血管性血友病因子可作为候选内皮相关标志物,反映疾病严重程度且在多数临床场景可及。不同基础疾病所致内皮功能障碍程度差异大,需进一步研究以建立个体化诊断标准。
要点
- DIC是伴随基础疾病的病理机制过程,内皮损伤为必要组分,但现行诊断标准未纳入内皮损伤标志物。
- 抗凝血酶活性和血管性血友病因子可作为候选内皮相关标志物,反映严重程度且临床可及。
- 不同基础疾病的内皮功能障碍程度不同:脓毒症相关凝血病显著,创伤相关凝血病中等,血液恶性肿瘤相关凝血病可变。
核心结论
- DIC是伴随多种基础疾病的病理机制过程,内皮损伤是必要组分,但现行诊断标准未纳入血管内皮损伤生物标志物。
- 目前尚无理想的内皮损伤生物标志物,抗凝血酶活性和血管性血友病因子可作为候选内皮相关标志物,因其反映严重程度且在多数临床场景可及。
- 不同基础疾病所致DIC的内皮功能障碍程度差异大,需进一步研究寻找临床可及的内皮相关生物标志物以建立个体化诊断标准和潜在治疗途径。
研究设计与样本
- 国际血栓与止血学会科学标准化委员会的通讯文件。
- 基于文献综述与专家观点,阐述DIC中血管内皮相关生物标志物的现状与研究方向。
主要发现
- 内皮细胞通过产生抗血栓物质、表达抗凝因子及促进凝血、炎症反应、血小板聚集和纤溶,在止血调控中起关键作用。
- 内皮细胞表达多种受体、黏附分子,糖萼在血栓炎症中调控细胞相互作用具有关键作用。
- 脓毒症相关凝血病中内皮功能障碍参与显著,创伤相关凝血病中为中等,血液恶性肿瘤相关凝血病中程度可变。
关键数值与推荐
- 国际血栓与止血学会定义:DIC除全身凝血激活外,内皮损伤是必要组分。
- 现行DIC诊断标准未纳入血管内皮损伤生物标志物。
- 抗凝血酶活性和血管性血友病因子可作为候选内皮相关标志物,因反映严重程度且在多数临床场景可及。
临床怎么用
- 原文未据此给出推荐。
局限性
- 目前尚无理想的内皮损伤生物标志物。
- 不同基础疾病所致DIC的内皮功能障碍程度差异大,需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Disseminated intravascular coagulation (DIC) is not a disease criterion but a pathomechanistic process that accompanies various underlying diseases. According to the International Society on Thrombosis and Haemostasis definition, endothelial injury is an essential component in addition to systemic coagulation activation. Despite this definition, current diagnostic criteria for DIC do not include biomarkers for vascular endothelial injury. Endothelial cells are critical for hemostatic regulation because they produce various antithrombotic substances and express anticoagulant factors at the same time as facilitating coagulation, inflammatory reactions, platelet aggregation, and fibrinolysis with acute injury. Endothelial cells also exhibit various receptors, adhesion molecules, and the critical role of glycocalyx that regulates cellular interactions in thromboinflammation. For clinicians, biomarkers suitable for assessing endothelial injury are not readily available. Although we still do not have ideal biomarkers, antithrombin activity and von Willebrand factor can be candidates for the endothelium-related markers because those reflect the severity and are available in most clinical settings. Further, the dysfunction of endothelial cell in DIC arising from various underlying diseases is likely highly variable. For example, the involvement of endothelial dysfunction is significant in sepsis-induced coagulopathy, while moderate in trauma-induced coagulopathy, and variable in hematologic malignancy-associated coagulopathy. Because of the complexity of disease status associated with DIC, further research searching clinically available endothelium-related biomarkers is expected to establish individualized diagnostic criteria and potential therapeutic approaches.
引用
- Iba T, Levy JH, Thachil J, et al. Communication from the Scientific Standardization Committees of the International Society on Thrombosis and Haemostasis on vascular endothelium-related biomarkers in disseminated intravascular coagulation. J Thromb Haemost. 2022. PMID: 36696178. doi:10.1016/j.jtha.2022.11.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。